ClC1C2NC(=O)C(C)(C)N=C(C3C=CC=CC=3F)C=2C=C([N+]([O-])=O)C=1.Cl[C:27]1[C:37]2[NH:36][C:35](=[O:38])[C:34]([CH3:40])([CH3:39])[N:33]=[C:32]([C:41]3[CH:46]=[CH:45][CH:44]=[CH:43][C:42]=3[Cl:47])[C:31]=2[CH:30]=[C:29]([N+:48]([O-:50])=[O:49])[CH:28]=1>CCOCC.CCCCCC>[Cl:47][C:42]1[CH:43]=[CH:44][CH:45]=[CH:46][C:41]=1[C:32]1[C:31]2[CH:30]=[C:29]([N+:48]([O-:50])=[O:49])[CH:28]=[CH:27][C:37]=2[NH:36][C:35](=[O:38])[C:34]([CH3:40])([CH3:39])[N:33]=1From 10 g (0.029 mol) of 5-(o-chlorophenyl)-1,3-dihydro-3,3-dimethyl-7-nitro-2H-1,4-benzodiazepin-2-one there is obtained, in analogy to the details in paragraph (a) of Example 13, 9-chloro-5-(o-chlorophenyl)-1,3-dihydro-3,3-dimethyl-7-nitro-2H-1,4-benzodiazepin-2-one of melting point 105° (ether/n-hexane).